Global Autoinjectors Industry 2016-2024 Credence ResearchPosted by Robson Tolson on March 30th, 2017 In the latest report published by Credence Research, Inc. “Global Autoinjectors industry (Manual Injection Autoinjectors, Automated Injection Autoinjectors, Reusable Autoinjectors, Disposable Autoinjectors, Variable Dose Autoinjectors & Smart Autoinjectors; & Therapeutic Areas) - Growth, Future Prospects & Competitive Assessment, 2016 - 2022,” the autoinjectors industry was valued at USD 869.0 Mn in 2015, & is expected to reach USD 2,740.7 Mn by 2022, exp&ing at a CAGR of 18% from 2016 to 2022. Browse the full report Global Autoinjectors industry - Growth, Opportunities, Competitive Analysis, & Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/autoinjectors-market Industry Insights The global autoinjectors industry is anticipated to undergo swift progress during the forecast period. This industry is characterized by rapid technological developments, growing count of severe allergy patients & growing awareness about self-administered prefilled injections. The demand for disposable autoinjectors will grow significantly during the forecast period. Due to corresponding demand from drug administration industry, the biopharmaceutical companies worldwide have introduced several solutions for injectable drug delivery & are perpetually pushing for improvements in design & mechanism. It is expected that a significant part of new treatment introductions in the industry will comprise of injectables, out of which autoinjectors is the fastest emerging drug delivery solutions, since these products deliver better patient experience & treatment adherence through safe self-administration at home. Apart from the offered patient benefits, reduction in the number of hospital visits can ultimately assist in reducing cost of healthcare & contain the burden on healthcare personnel. New ergonomic designs & mechanisms introduced in autoinjectors have also helped to efficiently address patient dexterity issues & minimize the risk of needle-stick injuries. Autoinjectors are being increasingly considered by biopharmaceutical companies as an appropriate solution to commercialize their therapeutic solutions. However for successful commercialization & implementation of related strategies, the companies require detailed planning, thorough knowledge of drug-device combination mechanism, regulatory requirements & synergy with device manufacturers. Acting against this, biopharmaceutical companies & device manufacturers have varied product lifecycles & thus product development process may lead to gaps that might be crucial for the overall project & affect commercialization & profitability. It is hence crucial for biopharmaceutical companies to have in-depth underst&ing of every intermediate stage, the stage of entry of device manufacturer, meeting regulatory mandates & other such processes. This industry is intensely competitive, yet a handful of players take over significant industry shares. Upcoming introductions of several autoinjector products in 2018 & future will bring significant movements in the overall autoinjectors industry. Some of the key players operating in development, manufacture & sale of autoinjectors in the international industrys are Biogen Idec, Inc., Becton, Dickinson & Company, Antares Pharma, Inc., Mylan, Inc., Novartis International AG, Unilife Corporation, Pfizer, Inc., Sc&inavian Health Ltd., Ypsomed Holding AG, Sanofi S. A., Bayer AG, Emergent BioSolutions & others. Browse Full Report At: https://goo.gl/GUU6Uy ToC: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Autoinjectors Market: Market Dynamics and Outlook Chapter 4 Global Autoinjectors Market Analysis, by Devices, 2013 - 2022 (USD Mn) Request Sample: http://www.credenceresearch.com/sample-request/58015 About Us: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task. Media Contact Name: Chris Smith Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US E-mail: sales@credenceresearch.com Ph: 1-800-361-8290 Like it? Share it! More by this author |